Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis

Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis

Saved in:

Bibliographic Details
Main Authors:	Gabriel Sauvage, Reza Zonozi, Harish Seethapathy, Orhan Efe, Anushya Jeyabalan, Karen Laliberte, John L. Niles, Ayman Al Jurdi
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Kidney International Reports
Subjects:	cyclophosphamide fibrillary fibrillary glomerulonephritis glomerular disease glomerulonephritis rituximab
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924033862
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Case of Fibrillary Glomerulonephritis – When You Least Expect It
by: Parixit Kiritkumar Gohil, et al.
Published: (2024-01-01)

Fibrillary Glomerulonephritis Diagnosis Is Enhanced by DNAJB9: Three Cases with Different Clinical, Anatomopathologic Features and Outcomes
by: José C. De La Flor, et al.
Published: (2025-05-01)

Glomerulonephritis associated with marginal zone B-cell lymphoma: clinical, pathological characteristics of renal injury and treatment (clinical cases)
by: B. T. Dzhumabaeva, et al.
Published: (2015-12-01)

Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
by: Rafeea Shah, et al.
Published: (2024-10-01)

Dual Occurrence of DNAJB-9 Positive Fibrillary Glomerulonephritis and Diffuse Lupus Nephritis: A Unique Overlap Glomerulopathy
by: Jonathan E. Zuckerman, et al.
Published: (2025-06-01)

Fibrillary glomerulonephritis disease natural history and outcomes: a retrospective two centre cohort study
by: Yimeng Zhang, et al.
Published: (2025-07-01)

Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis
by: Stephen P. McAdoo, et al.
Published: (2025-06-01)

Advances in Multitarget Therapeutic Approaches for Immune-Mediated Glomerular Diseases
by: Luminita Voroneanu, et al.
Published: (2025-02-01)

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease
by: Vanja Ivković, et al.
Published: (2025-03-01)

Effectiveness of using rituximab in membranous nephropathy: a clinical case
by: I.M. Zavalna, et al.
Published: (2024-09-01)

Persistent B Cell Depletion After Rituximab for Autoimmune and Glomerular Diseases: A Case Series
by: Orhan Efe, et al.
Published: (2025-05-01)

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
by: Paolo Cravedi, et al.
Published: (2024-11-01)

Serum cystatin C as a marker of glomerular kidney damage in patients with chronic glomerulonephritis with saved renal function
by: O. V. Kraydashenko, et al.
Published: (2015-06-01)

The research progress of podocytes in crescentic glomerulonephritis
by: ZOU Rong, et al.
Published: (2020-01-01)

Undifferentiated connective tissue disease with fibrillary glomerulopathy：one case report with a literature review
by: Xue Hen, et al.
Published: (2022-06-01)

Effect of low-dose rituximab on elderly patients with high risk membranous nephropathy： 2 cases and literature review
by: Zhao Xiao-yan, et al.
Published: (2025-02-01)

Effect of low-dose rituximab on elderly patients with high risk membranous nephropathy： 2 cases and literature review
by: Zhao Xiao-yan, et al.
Published: (2025-02-01)

Recent advances in the diagnosis and treatment of membranoproliferative glomerulonephritis with monoclonal immunoglobulin deposition
by: Zhang Yuan-yuan, et al.
Published: (2022-03-01)

“Normal” Glomerular Score Correlates With Outcomes in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis With Glomerulonephritis
by: Marta Casal Moura, et al.
Published: (2025-02-01)

Predictors of renal outcome in ANCA-assosiated glomerulonephritis
by: Ljubičić Bojana, et al.
Published: (2021-01-01)

Effect of self-management support on the progression of primary chronic glomerulonephritis
by: QIN Xin-dong, et al.
Published: (2015-01-01)

SUBCLINICAL LESION OF CAROTID ARTERIES IN CHRONIC GLOMERULONEPHRITIS
by: I. T. Murkamilov, et al.
Published: (2017-08-01)

Clinico-morphological comparison of the mesangiocapillary glomerulonephritis type I and diffuse lupus glomerulonephritis
by: О. V. Khmara, et al.
Published: (2013-12-01)

Plasma concentrations of neurofilament light, p-Tau231 and glial fibrillary acidic protein are elevated in patients with chronic kidney disease and correlate with measured glomerular filtration rate
by: Torunn Axelsson, et al.
Published: (2025-05-01)

Predictive factors of progression to chronic glomerulonephritis in pediatric patients with post streptococcal acute glomerulonephritis
by: Ida Ayu Laksmi Arnita Utari, et al.
Published: (2024-11-01)

A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
by: Mehri Salari, et al.
Published: (2023-03-01)

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy
by: Tao Wang, et al.
Published: (2025-12-01)

Combination Cyclophosphamide and Rituximab to Minimize Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis
by: Tania Salehi, et al.
Published: (2025-07-01)

Fibrillary glomerulopathy:one case report and literature review
by: LV Qian, et al.
Published: (2015-01-01)

The role of repeat kidney biopsy in patients with lupus nephritis (case report)
by: N. Yu. Nikishin, et al.
Published: (2024-04-01)

Recurrent Crescentic Infection Related Glomerulonephritis: a rare presentation
by: Kapil Naveen Sejpal, et al.
Published: (2022-01-01)

Primary Sjögren’s syndrome presenting with non-diffuse membranoproliferative glomerulonephritis-like lesions in cryoglobulinemic glomerulonephritis: a case report
by: Zhi-Yu Duan, et al.
Published: (2025-05-01)

Complement in anti-glomerular basement membrane glomerulonephritis
by: Pei Zhang, et al.
Published: (2025-05-01)

Predicting ICU Admission in Patients with Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
by: Su XH, et al.
Published: (2025-08-01)

Glial Fibrillary Acidic Protein’s Usefulness as an Astrocyte Biomarker Using the Fully Automated LUMIPULSE<sup>®</sup> System
by: Jo Kamada, et al.
Published: (2024-11-01)

Clinical observation of monoclonal fibrillary glomerulonephritis
by: T. A. Garkusha, et al.
Published: (2025-02-01)

Myeloperoxidase-Associated Membranous Nephropathy in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis
by: Kenta Tominaga, et al.
Published: (2024-07-01)

Clinical efficacy of benazepril and irbesartan for children with chronic glomerulonephritis
by: LIU Xiao-yan
Published: (2016-01-01)

Serum Glial Fibrillary Acidic Protein and S100B Profiles in Severity and Outcome Assessment of Moderate and Severe Head Injury Patients in India
by: Arpana Singh, et al.
Published: (2024-10-01)

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01)